Login / Signup

Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis.

Juan AguilarIbai Los ArcosCarles PigrauDolors Rodríguez-PardoMaría Nieves LarrosaVirginia Rodríguez-GarridoDenisse Sihuay-DiburgaBenito Almirante
Published in: Antimicrobial agents and chemotherapy (2016)
We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.
Keyphrases
  • biofilm formation
  • escherichia coli
  • antimicrobial resistance
  • urinary tract infection
  • gram negative
  • pseudomonas aeruginosa
  • staphylococcus aureus
  • genetic diversity
  • cystic fibrosis
  • risk assessment
  • human health